(From Adaptogeno) Scientists of United States claim that in about two years for cancer could be cured by injections of immune cells from other people. The scientists have received approval from the FDA to start testing in human blood cells of anti-"super strong" from donors.Dr. Zheng Cui, of the Faculty of Medicine at Wake Forest University, has been shown in laboratory experiments that immune cells from some people may be nearly 50 times more effective in fighting cancer than in others. Dr. Cui, whose work has been highlighted in this week's New Scientist magazine, had previously shown that cells from mice immune to cancer could be used to protect and even cured tumors in other mice.
In 1999, Dr. Cui and his colleagues discovered a male mouse that appeared to be completely resistant cells of different types of cancers virulent. Dr. Cui injected granulocytes from immune mice in normal mice and found that a single dose could provide protection against cancer for life. In addition, he discovered that transfusions referred cancer patients arriving in mice, in some cases, to eliminate it entirely in weeks.
The work raises the possibility of using in human granulocytes, immune system cells that fight cancer, obtained from donors for to boost significantly the ability of patients to combat their disease and perhaps even cured. According to Cui, if this method proves to be as effective in humans as in mice, it could save many lives, and soon, because the technology needed to extract granulocytes and put it into practice is the same as that used in hospitals to obtain other blood components, such as plasma or platelets.
The Dr. Cui, who presented their latest findings at a conference on anti-aging in Cambridge recently, extracted granulocytes from 100 people, including some cancer patients. By mixing the immune cells with cancer, their combat capability varied greatly from one individual to another. The strongest of individuals dropped almost 97% of cancer cells in 24 hours, while those of the weakest just dropped by two percent.
.



